Top Markets
#1 TENDIES TENDIES +60.57%
#2 Threshold Network Threshold Network +53.84%
#3 Cash Cat Cash Cat +23.29%
#4 OSK OSK +16.15%
#5 Falcon Finance Falcon Finance +14.06%
#6 Magma Finance Magma Finance +13.46%
#7 Kite Kite +12.68%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 Maple Finance Maple Finance +12.49%
#10 Kinetiq Kinetiq +10.94%
Coin of the day
TENDIES TENDIES
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Cellectis S.A. Cellectis S.A.

Cellectis S.A.

ALCLS
Classificação em ações #17187
Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and... Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and headquartered in Paris, France, concentrates on immuno-oncology. The firm engineers therapeutic solutions utilizing gene-edited T-cells, which are modified to display chimeric antigen receptors (CARs) for the specific identification and destruction of cancer cells. Its operations are divided into two principal segments: Therapeutics and Plants. The company's pipeline features several allogeneic CAR T-cell product candidates. These include UCART19, aimed at CD19-expressing hematologic malignancies such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A, developed to treat relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316, targeting renal cell carcinoma; UCART123, for acute myeloid leukemia; and UCART22, addressing B-cell acute lymphoblastic leukemia. Additionally, Cellectis is advancing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. Cellectis has forged significant strategic partnerships and alliances with companies including Allogene Therapeutics, Inc., Les Laboratoires Servier, The University of Texas M.D. Anderson Cancer Center, and Iovance Biotherapeutics. It also maintains a strategic research and development collaboration with Cytovia Therapeutics, Inc.
Preço da ação
$3.55
Valor de mercado
$256.68M
Variação (1 dia)
4.98%
Variação (1 ano)
37.99%
País
FR
Negociar Cellectis S.A. (ALCLS)

Categoria

Healthcare
Histórico de dividendos de Cellectis S.A. (ALCLS)
Cellectis S.A. (símbolo da ação: ALCLS) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Cellectis S.A. (ALCLS) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH